Jim Simons’s Pacira BioSciences PCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $55.1M | Sell |
|
|||||
|
2025
Q2 | $57.3M | Buy |
|
|||||
|
2025
Q1 | $55.7M | Buy |
|
|||||
|
2024
Q4 | $37.5M | Buy |
|
|||||
|
2024
Q3 | $29.8M | Sell |
|
|||||
|
2024
Q2 | $59.1M | Buy |
|
|||||
|
2024
Q1 | $55M | Buy |
|
|||||
|
2023
Q4 | $57.9M | Buy |
|
|||||
|
2023
Q3 | $49.5M | Buy |
|
|||||
|
2023
Q2 | $63.1M | Buy |
|
|||||
|
2023
Q1 | $63.6M | Sell |
|
|||||
|
2022
Q4 | $61.3M | Sell |
|
|||||
|
2022
Q3 | $93.3M | Sell |
|
|||||
|
2022
Q2 | $115M | Buy |
|
|||||
|
2022
Q1 | $142M | Buy |
|
|||||
|
2021
Q4 | $111M | Sell |
|
|||||
|
2021
Q3 | $110M | Sell |
|
|||||
|
2021
Q2 | $125M | Sell |
|
|||||
|
2021
Q1 | $162M | Sell |
|
|||||
|
2020
Q4 | $157M | Sell |
|
|||||
|
2020
Q3 | $167M | Sell |
|
|||||
|
2020
Q2 | $150M | Buy |
|
|||||
|
2020
Q1 | $82.8M | Buy |
|
|||||
|
2019
Q4 | $81.4M | Buy |
|
|||||
|
2019
Q3 | $46.3M | Buy |
|
|||||
|
2019
Q2 | $47.5M | Buy |
|
|||||
|
2019
Q1 | $40.5M | Buy |
|
|||||
|
2018
Q4 | $15.3M | Buy |
|
|||||
|
2018
Q3 | $3.65M | Buy |
|
|||||
|
2018
Q1 | – | Sell |
|
|||||
|
2017
Q4 | $23.3M | Buy |
|
|||||
|
2017
Q3 | $14.1M | Buy |
|
|||||
|
2017
Q2 | $849K | Buy |
|
|||||
|
2017
Q1 | – | Sell |
|
|||||
|
2016
Q4 | $814K | Buy |
|
|||||
|
2016
Q3 | $849K | Sell |
|
|||||
|
2016
Q2 | $1.17M | Buy |
|
|||||
|
2015
Q4 | – | Sell |
|
|||||
|
2015
Q3 | $4.46M | Buy |
|
|||||
|
2015
Q1 | – | Sell |
|
|||||
|
2014
Q4 | $869K | Sell |
|
|||||
|
2014
Q3 | $3.86M | Buy |
|
|||||
|
2014
Q2 | – | Sell |
|
|||||
|
2014
Q1 | $12M | Buy |
|
|||||
|
2013
Q4 | $4.11M | Buy |
|